Rezolute (RZLT) Payables (2011 - 2026)
Rezolute (RZLT) posted Payables of $3.2 million for Q1 2026, down 15.54% sequentially from $3.8 million in Q4 2025, and down 50.86% YoY from $6.5 million in Q1 2025.
Rezolute (RZLT) Payables (2011 - 2026) Analysis & Trends
Rezolute has reported Payables for 16 years, with the latest figure at $3.2 million in Q1 2026.
- Quarterly Payables fell 50.86% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 50.86% YoY) and the FY2025 annual result came in at $5.8 million, up 18.53% from the prior year.
- Payables retreated to $3.2 million in Q1 2026 per RZLT's latest filing, from $3.8 million in the prior quarter.
- Over five years, Payables peaked at $6.5 million in Q1 2025 and troughed at $1.1 million in Q3 2022.
- A 5-year average of $3.2 million and a median of $3.2 million in 2026 frame the typical range for Payables.
- The sharpest annual moves came in 2023 and 2026: Payables soared 188.78% in 2023, then tumbled 50.86% in 2026.
- Over 5 years, Payables stood at $2.8 million in 2022, then advanced by 26.47% to $3.6 million in 2023, then fell by 12.36% to $3.1 million in 2024, then gained by 20.13% to $3.8 million in 2025, then declined by 15.54% to $3.2 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $3.2 million, $3.8 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | 3.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.20 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Sep 30, 2025 | 3.26 Mn |
| Jun 30, 2025 | 5.81 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Dec 31, 2024 | 3.15 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Jun 30, 2024 | 4.90 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Dec 31, 2023 | 3.59 Mn |
| Sep 30, 2023 | 2.43 Mn |
| Jun 30, 2023 | 3.27 Mn |
| Mar 31, 2023 | 2.95 Mn |
| Dec 31, 2022 | 2.84 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 1.13 Mn |
| Mar 31, 2022 | 1.56 Mn |
| Dec 31, 2021 | 4.35 Mn |
| Sep 30, 2021 | 1.59 Mn |
| Jun 30, 2021 | 1.04 Mn |